🇺🇸 FDA
Patent

US 6103690

Prevention or inhibition of pathogenic syndromes caused by nitric oxide overproduction using iron-containing hemoprotein

expired A61KA61K38/42A61P

Quick answer

US patent 6103690 (Prevention or inhibition of pathogenic syndromes caused by nitric oxide overproduction using iron-containing hemoprotein) held by The Board of Regents of the University of Texas System expires Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/42, A61P, A61P9/00, A61P9/12